James G Boyle Selected Research

Inflammation (Inflammations)

1/2018

Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James G Boyle Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 12/2022 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2022 - 01/2017
1	Weight Gain 12/2022
1	Insulin Resistance 01/2022
1	Schizophrenia (Dementia Praecox) 11/2019
1	Inflammation (Inflammations) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Overweight 01/2017
1	Atherosclerosis 01/2017
1	Neoplasms (Cancer) 01/2011
1	Infections 04/2008
1	Pheochromocytoma 12/2007

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 12/2022 - 01/2017
3	Metformin (Glucophage)FDA LinkGeneric 12/2022 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 01/2017
2	LDL CholesterolIBA 01/2018 - 01/2017
2	CatecholaminesIBA 01/2011 - 12/2007
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2022
1	SodiumIBA 12/2022
1	Islet Amyloid PolypeptideIBA 12/2022
1	dapagliflozinIBA 12/2022
1	pramlintide (Symlin)FDA Link 12/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Testosterone (Sustanon)FDA Link 01/2021
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	CholesterolIBA 11/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	FlavonolsIBA 01/2011
1	Dopamine (Intropin)FDA LinkGeneric 01/2011
1	Homovanillic AcidIBA 01/2011
1	AMP-Activated Protein KinasesIBA 04/2008
1	Rosiglitazone (Avandia)FDA Link 04/2008
1	mandelic acidIBA 12/2007

Therapy/Procedure

3	Therapeutics 12/2022 - 01/2017
1	Glycemic Control 12/2022